The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier
Open accessAbstract
AIM: To investigate whether gut microbiota metabolite sodium butyrate (NaB) is an effective substance for attenuating non-alcoholic fatty liver disease (NAFLD) and the internal mechanisms. METHODS: Male C57BL/6J mice were divided into three groups, normal control were fed standard chow and model group were fed a high-fat diet (HFD) for 16 wk, the intervention group were fed HFD for 16 wk and treated with NaB for 8 wk. Gut microbiota from each group were detected at baseline and at 16 wk, liver histology were evaluated and gastrointestinal barrier indicator such as zonula occluden-1 (ZO-1) were detected by immunohistochemistry and realtime-PCR, further serum or liver endotoxin were determined by ELISA and inflammation- or metabolism-associated genes were quantified by real-time PCR. RESULTS: . These bacteria can produce butyric acid in what seems like a virtuous circle. And butyrate restored HFD induced intestinal mucosa damage, increased the expression of ZO-1 in small intestine, further decreased the levels of gut endotoxin in serum and liver compared with HF group. Endotoxin-associated genes such as TLR4 and Myd88, pro-inflammation genes such as MCP-1, TNF-α, IL-1, IL-2, IL-6 and IFN-γ in liver or epididymal fat were obviously downregulated after NaB intervention. Liver inflammation and fat accumulation were ameliorated, the levels of TG and cholesterol in liver were decreased after NaB intervention, NAS score was significantly decreased, metabolic indices such as FBG and HOMA-IR and liver function indicators ALT and AST were improved compared with HF group. CONCLUSION: NaB may restore the dysbiosis of gut microbiota to attenuate steatohepatitis, which is suggested to be a potential gut microbiota modulator and therapeutic substance for NAFLD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Zhou et al. reported that sodium butyrate (NaB) reduced the entry of inflammatory factors into the liver by regulating gut microbial dysbiosis, thereby reducing steatohepatitis induced by a high-fat diet [21].”
From Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease (2023) · cites this paper as [21]
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164
Cited by
Sorted by citations
Short chain fatty acids in human gut and metabolic health
Blaak, E. E., Canfora, E. E., Theis, S., Frost, G., Groen, A. K., Mithieux, G., Nauta, A., Scott, K., Stahl, B., van Harsselaar, J., et al. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0057 · Cited by 1,103
Short-chain fatty acids in diseases
Zhang, D., Jian, Y., Zhang, Y., Li, Y., Gu, L.-T., Sun, H.-H., Liu, M., Zhou, H., Wang, Y., & Xu, Z. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01219-9 · Cited by 813
Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health
Chambers, E. S., Preston, T., Frost, G., & Morrison, D. J. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0248-8 · Cited by 691
The role of the microbiome in NAFLD and NASH
Kolodziejczyk, A. A., Zheng, D., Shibolet, O., & Elinav, E. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809302 · Cited by 523
Li, H., Zhou, D.-D., Gan, R., Huang, S., Zhao, C., Shang, A., Xu, X., & Li, H. (2021) · Nutrients · doi:10.3390/nu13093211 · Cited by 514
Self-citationContribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Chopyk, D. M., & Grakoui, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.077 · Cited by 504
Role of the gut microbiota in type 2 diabetes and related diseases
Yang, G., Wei, J., Liu, P., Zhang, Q., Tian, Y., Hou, G., Meng, L., Xin, Y., & Jiang, X. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154712 · Cited by 418
The Role of Short Chain Fatty Acids in Inflammation and Body Health
Du, Y., He, C., An, Y., Huang, Y., Zhang, H., Fu, W., Wang, M., Shan, Z., Xie, J., Yang, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137379 · Cited by 444
Self-citationFacchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., Barba, C. D., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 455
Xu, X., Poulsen, K. L., Wu, L., Liu, S., Miyata, T., Song, Q., Wei, Q., Zhao, C., Lin, C., & Yang, J. B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01119-3 · Cited by 387
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Chen, J., & Vitetta, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155214 · Cited by 370
Zhao, Z., Xin, F., Xue, Y., Hu, Z., Han, Y., Ma, F., Zhou, D., Liu, X., Cui, A., Liu, Z., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0304-5 · Cited by 357
Self-citationLean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
Chen, F., Esmaili, S., Rogers, G. B., Bugianesi, E., Petta, S., Marchesini, G., Bayoumi, A., Metwally, M., Azardaryany, M. K., Coulter, S., et al. (2019) · Hepatology · doi:10.1002/hep.30908 · Cited by 338
Biological Function of Short-Chain Fatty Acids and Its Regulation on Intestinal Health of Poultry
Liu, L., Li, Q., Yang, Y., & Guo, A. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.736739 · Cited by 356
Li, J.-M., Yu, R., Zhang, L.-P., Wen, S.-Y., Wang, S.-J., Zhang, X.-Y., Xu, Q., & Kong, L.-D. (2019) · Microbiome · doi:10.1186/s40168-019-0713-7 · Cited by 300
Kang, C., Wang, B., Kaliannan, K., Wang, X., Lang, H., Hui, S., Huang, L., Zhang, Y., Zhou, M., Chen, M., et al. (2017) · mBio · doi:10.1128/mbio.00470-17 · Cited by 279
The Protective Role of Butyrate against Obesity and Obesity-Related Diseases
Coppola, S., Avagliano, C., Calignano, A., & Canani, R. B. (2021) · Molecules · doi:10.3390/molecules26030682 · Cited by 272
Lactobacillus and intestinal diseases: Mechanisms of action and clinical applications
Huang, R., Wu, F. L., Zhou, Q., Wei, W., Juan, Y., Xiao, B., & Luo, Z. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127019 · Cited by 268
Role of gut microbiota on intestinal barrier function in acute pancreatitis
Li, X.-Y., He, C., Zhu, Y., & Lü, N. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i18.2187 · Cited by 258
Self-citationJi, Y. S., Yin, Y., Li, Z., & Zhang, W. (2019) · Nutrients · doi:10.3390/nu11081712 · Cited by 235
Zhou, D., Chen, Y., Zhao, Z., Yang, R., Xin, F., Liu, X., Pan, Q., Zhou, H., & Fan, J. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0183-1 · Cited by 228
Self-citationBeisner, J., Rosa, L. F., Kaden-Volynets, V., Stolzer, I., Günther, C., & Bischoff, S. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678360 · Cited by 218
Ye, J., Lv, L., Wu, W., Li, Y., Shi, D., Fang, D., Guo, F., Jiang, H., Ren, Y., Ye, W., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01967 · Cited by 211
Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy
Ma, J., Zhou, Q., & Li, H. (2017) · Nutrients · doi:10.3390/nu9101124 · Cited by 197
Lambertz, J., Weiskirchen, S., Landert, S., & Weiskirchen, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01159 · Cited by 195
Metformin attenuated sepsis-related liver injury by modulating gut microbiota
Liang, H., Song, H., Zhang, X., Song, G., Wang, Y., Ding, X., Duan, X., Li, L., Sun, T., & Kan, Q. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2045876 · Cited by 177
Comparison of Fecal Collection Methods for Microbiome and Metabolomics Studies
Wang, Z., Zolnik, C. P., Qiu, Y., Usyk, M., Wang, T., Strickler, H. D., Isasi, C. R., Kaplan, R. C., Kurland, I. J., Qi, Q., et al. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00301 · Cited by 166
Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
Iacob, S. A., & Iacob, D. G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01676 · Cited by 158
van Deuren, T., Blaak, E. E., & Canfora, E. E. (2022) · Obesity Reviews · doi:10.1111/obr.13498 · Cited by 169
Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22–dependent manner
Busbee, P. B., Menzel, L. P., Alrafas, H. R., Dopkins, N., Becker, W., Miranda, K., Tang, C., Chatterjee, S., Singh, U. P., Nagarkatti, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.127551 · Cited by 162
Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders
Maioli, T. U., Nogués, E. B., Torres, L., Barbosa, S. C., Martins, V. D., Langella, P., Azevedo, V., & Chatel, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.740636 · Cited by 159
Lange, O., Proczko-Stepaniak, M., & Mika, A. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00503-6 · Cited by 168
Tang, W., Yao, X., Xia, F., Yang, M., Chen, Z., Zhou, B., & Liu, Q. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7261619 · Cited by 151
Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease
Couto, M. R., Gonçalves, P., Magro, F., & Martel, F. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104947 · Cited by 153
Chen, M., Hou, P., Zhou, M., Ren, Q., Wang, X., Huang, L., Hui, S., Yi, L., & Mi, M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.05.020 · Cited by 148
Qiao, S., Li, B., Wang, K., Sun, S., Liao, M., Liu, C., Zhou, N., Ma, K., Zhang, Y., Chen, Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108005 · Cited by 147
Self-citationWu, W., Xiao, Z., An, W., Dong, Y., & Zhang, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197762 · Cited by 146
The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
Song, Q., & Zhang, X. (2022) · Biomedicines · doi:10.3390/biomedicines10030524 · Cited by 154
Zhou, W., Yang, T., Xu, W., Huang, Y., Ran, L., Yan, Y., Mi, J., Lu, L., Sun, Y., Zeng, X., et al. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119626 · Cited by 149
Meroni, M., Longo, M., & Dongiovanni, P. (2019) · Nutrients · doi:10.3390/nu11112642 · Cited by 152
Butyrate as a bioactive human milk protective component against food allergy
Paparo, L., Nocerino, R., Ciaglia, E., Scala, C. D., Caro, C. D., Russo, R., Trinchese, G., Aitoro, R., Amoroso, A., Bruno, C., et al. (2020) · Allergy · doi:10.1111/all.14625 · Cited by 141
Mitotherapy for Fatty Liver by Intravenous Administration of Exogenous Mitochondria in Male Mice
Fu, A., Shi, X., Zhang, H., & Fu, B. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00241 · Cited by 139
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
Han, H. L., Jiang, Y., Wang, M., Melaku, M., Liu, L., Zhao, Y. M., Everaert, N., Yi, B., & Zhang, H. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1966738 · Cited by 135
Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota
Loke, Y. L., Chew, M. T., Ngeow, Y. F., Lim, W. W.-D., & Peh, S. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.603086 · Cited by 138
Chen, H., Qian, Y., Jiang, C., Tang, L., Yu, J., Zhang, L., Dai, Y., & Jiang, G. Z. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166984 · Cited by 136
Khan, A., Ding, Z., Ishaq, M. H., Bacha, A. S., KHAN, I. A., Hanif, A., Li, W., & Guo, X. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56214 · Cited by 130
Gao, X., Chang, S., Liu, S., Peng, L., Xie, J., Dong, W., Tian, Y., & Sheng, J. (2020) · mSystems · doi:10.1128/msystems.00391-20 · Cited by 122
Zhao, Z., Wang, Z., Zhou, D., Han, Y., Ma, F., Hu, Z., Xin, F., Liu, X., Ren, T., Zhang, F., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.05.006 · Cited by 113
Self-citationLiu, W., Luo, X., Tang, J., Mo, Q., Zhong, H., Zhang, H., & Feng, F. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02431-w · Cited by 111
Sun, B., Jia, Y., Hong, J., Sun, Q., Gao, S., Hu, Y., Zhao, N., & Zhao, R. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01189 · Cited by 108
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy
Zhang, Y., Xiao, Z., Yu, X., Novák, P., Gui, Q., & Yin, K. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1120168 · Cited by 112
Dietary butyrate suppresses inflammation through modulating gut microbiota in high-fat diet-fed mice
Zhai, S., Qin, S., Li, L., Zhu, L., Zou, Z., & Wang, L. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz153 · Cited by 101
Li, J., Fang, B., Pang, G., Zhang, M., & Ren, F. (2019) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2019.05.018 · Cited by 107
Whole food-based approaches to modulating gut microbiota and associated diseases
Han, Y., & Xiao, H. (2020) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-111519-014337 · Cited by 101
Ding, Q., Cao, F., Lai, S., Zhuge, H., Chang, K., Valencak, T. G., Liu, J., Li, S., & Ren, D. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111259 · Cited by 101
Sodium butyrate in both prevention and supportive treatment of colorectal cancer
Kaźmierczak-Siedlecka, K., Marano, L., Merola, E., Roviello, F., & Połom, K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1023806 · Cited by 113
Microbial Metabolites: Critical Regulators in NAFLD
Dai, X., Hou, H., Zhang, W., Liu, T., Li, Y., Wang, S., Wang, B., & Cao, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.567654 · Cited by 103
Capsaicin and Gut Microbiota in Health and Disease
Roşca, A. E., Ieșanu, M. I., Zahiu, C. D. M., Voiculescu, S. E., Paslaru, A. C., & Zăgrean, A. (2020) · Molecules · doi:10.3390/molecules25235681 · Cited by 105
Horvath, A., Leber, B., Feldbacher, N., Tripolt, N. J., Rainer, F., Blesl, A., Trieb, M., Marsche, G., Sourij, H., & Stadlbauer, V. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02135-w · Cited by 103
Microbial metabolites in non-alcoholic fatty liver disease
Zhou, D., & Fan, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i17.2019 · Cited by 96
Self-citationLiraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice
Liu, Q., Cai, B.-Y., Zhu, L., Xin, X., Wang, X., An, Z., Li, S., Hu, Y., & Feng, Q. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118457 · Cited by 92
Overview of the Importance of Biotics in Gut Barrier Integrity
Kocot, A. M., Jarocka‐Cyrta, E., & Drabińska, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052896 · Cited by 101
Zhong, Y., Wang, T., Luo, R., Liu, J., Jin, R., & Peng, X. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2158174 · Cited by 98
The Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity
You, H., Tan, Y., Yu, D., Qiu, S., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.886902 · Cited by 99
Chen, M., Hui, S., Lang, H., Zhou, M., Zhang, Y., Kang, C., Zeng, X., Zhang, Q., Yi, L., & Mi, M. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800612 · Cited by 85
Dai, X., Guo, Z., Chen, D., Li, L., Song, X., Liu, T., Jin, G., Li, Y., Liu, Y., Ajiguli, A., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1738187 · Cited by 89
Wang, Q., Xu, K., Cai, X., Wang, C., Cao, Y., & Xiao, J. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c08444 · Cited by 90
Butyrate: A potential mediator of obesity and microbiome via different mechanisms of actions
Güler, M. S., Arslan, S., Ağagündüz, D., Cerqua, I., Pagano, E., Canani, R. B., & Capasso, R. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115420 · Cited by 92
Wang, G., Sun, S., Wu, X., Yang, S., Wu, Y., Zhao, J., Zhang, H., & Chen, W. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110590 · Cited by 84
New insights in gut microbiota and mucosal immunity of the small intestine
Million, M., Tomas, J., Wagner, C., Lelouard, H., Raoult, D., & Gorvel, J. (2018) · Human Microbiome Journal · doi:10.1016/j.humic.2018.01.004 · Cited by 85
Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
Hyun, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179139 · Cited by 87
Guo, T.-T., Zhang, Z., Sun, Y., Zhu, R.-Y., Wang, F.-X., Ma, L.-J., Jiang, L., & Liu, H.-D. (2023) · Nutrients · doi:10.3390/nu15040930 · Cited by 82
A double‐edged sword: Role of butyrate in the oral cavity and the gut
Guan, X., Li, W., & Meng, H. (2020) · Molecular Oral Microbiology · doi:10.1111/omi.12322 · Cited by 79
Butyrate prevents valproate‐induced liver injury: In vitro and in vivo evidence
Pirozzi, C., Lama, A., Annunziata, C., Cavaliere, G., Caro, C. D., Citraro, R., Russo, E., Tallarico, M., Iannone, M., Ferrante, M. C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900927rr · Cited by 77
Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
Jiang, X., Zheng, J., Zhang, S., Wang, B., Wu, C., & Guo, X. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00361 · Cited by 80
Brown, K., Abbott, D. W., Uwiera, R. R. E., & Inglis, G. D. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1408763 · Cited by 78
Xin, F., Zhao, Z., Liu, X., Pan, Q., Wang, Z., Zeng, L., Zhang, Q., Ye, L., Wang, M., Zhang, R.-N., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.12.003 · Cited by 76
Self-citationButyrate and obesity: Current research status and future prospect
Peng, K., Dong, W., Luo, T., Tang, H., Zhu, W., Huang, Y., & Yang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1098881 · Cited by 81
Miranda, C. L., Johnson, L. A., de Montgolfier, O., Elias, V. D., Ullrich, L. S., Hay, J. J., Paraiso, I. L., Choi, J., Reed, R. L., Revel, J. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18992-6 · Cited by 75
Peng, J., Leng, J., Tian, H., Yang, T., Fang, Y., Feng, Q., Zhao, Y., & Hu, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01399 · Cited by 75
Kundi, Z. M., Lee, J. C., Pihlajamäki, J., Chan, C. B., Leung, K. S., So, S. S. Y., Nordlund, E., Kolehmainen, M., & El-Nezami, H. S. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900580 · Cited by 77
High-Fat Diet Alters the Intestinal Microbiota in Streptozotocin-Induced Type 2 Diabetic Mice
Liu, S., Qin, P., & Wang, J. (2019) · Microorganisms · doi:10.3390/microorganisms7060176 · Cited by 80
Fecal Transplantation from db/db Mice Treated with Sodium Butyrate Attenuates Ischemic Stroke Injury
Wang, H., Song, W., Wu, Q., Gao, X., Li, J., Tan, C., Zhou, H., Zhu, J., He, Y., & Yin, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00042-21 · Cited by 75
Pan, X., Kaminga, A. C., Liu, A., Wen, S. W., Luo, M., & Luo, J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.683743 · Cited by 68
Pohl, K., Moodley, P., & Dhanda, A. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15899 · Cited by 70
Liu, T., Sun, Z., Yang, Z., & Qiao, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114586 · Cited by 69
The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
Hliwa, A., Ramos‐Molina, B., Łaski, D., Mika, A., & Śledziński, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136900 · Cited by 68
Zhang, J., Zhong, L., Chi, S., Chu, W., Liu, Y., & Hu, Y. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.734952 · Cited by 66
Verdugo‐Meza, A., Ye, J., Dadlani, H., Ghosh, S., & Gibson, D. L. (2020) · Nutrients · doi:10.3390/nu12051434 · Cited by 69
Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota
Wisniewski, P. J., Dowden, R. A., & Campbell, S. C. (2019) · Nutrients · doi:10.3390/nu11010117 · Cited by 66
Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases
Asif, S., Morrow, N. M., Mulvihill, E. E., & Kim, K.-H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.590369 · Cited by 69
Zhao, T., Zhan, L., Zhou, W., Chen, W., Luo, J., Zhang, L., Weng, Z., Zhao, C., & Liu, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.647529 · Cited by 61
Zhao, Y., Sun, H., Chen, Y., Niu, Q., Dong, Y., Li, M., Yuan, Y., Yang, X., & Sun, Q. (2023) · mBio · doi:10.1128/mbio.01987-23 · Cited by 62
Self-citationShashni, B., Tajika, Y., Ikeda, Y., Nishikawa, Y., & Nagasaki, Y. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122047 · Cited by 59
Zhao, H., Gao, X., Liu, Z., Zhang, L., Fang, X., Sun, J., Zhang, Z., & Sun, Y. (2022) · Nutrients · doi:10.3390/nu14224846 · Cited by 58
Li, Y., Li, H., Wang, R., Yu, Y., Liu, X., & Tian, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114568 · Cited by 65
The Role of Intestinal Flora in the Regulation of Bone Homeostasis
Li, C., Pi, G., & Li, F. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.579323 · Cited by 59
Wang, K., Li, B., Zhou, N., Zhang, J., Liao, M., Zheng, Z., Wang, Y., Liu, C., Wang, J., Wang, L., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00107 · Cited by 57
Self-citationNon-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies
Leylabadlo, H. E., Ghotaslou, R., Kafil, H. S., Feizabadi, M. M., Moaddab, S. Y., Farajnia, S., Sheykhsaran, E., Sanaie, S., Shanehbandi, D., & Baghi, H. B. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03746-1 · Cited by 56
The Gut Microbial Endocrine Organ in Type 2 Diabetes
Massey, W. J., & Brown, J. M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa235 · Cited by 61
Metadata
- Authors
- Zhou, D., Pan, Q., Xin, F.-Z., Zhang, R.-N., He, C.-X., Chen, G.-Y., Liu, C., Chen, Y.-W., & Fan, J.-G.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2017
- Volume
- 23
- Issue
- 1
- Pages
- 60
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC5221287
- OpenAlex
- W2571212804
- Cited by
- 441
- References
- 56
- Citations by year
- 2026: 34 · 2025: 61 · 2024: 66 · 2023: 58 · 2022: 68 · 2021: 46 · 2020: 50 · 2019: 30 · 2018: 17 · 2017: 11
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- sodium butyrate, non-alcoholic fatty liver disease, steatohepatitis, high-fat diet, gut microbiota, intestinal barrier, zonula occludens-1, endotoxin, gut-liver axis, gut dysbiosis, inflammation, insulin resistance, butyrate
- MeSH terms
- Gastrointestinal Microbiome, Animals, Drug Evaluation, Preclinical, Humans, Immunohistochemistry, Inflammation, Intestinal Mucosa, Lactobacillus, Liver, Liver Function Tests, Male, Mice, Inbred C57BL, Specific Pathogen-Free Organisms, Tumor Necrosis Factor-alpha, Cytokines, Butyric Acid, Mice, Diet, High-Fat, Real-Time Polymerase Chain Reaction, Zonula Occludens-1 Protein, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review